Eurofins Food and Water Testing UK and Ireland has strengthened its position as a leader in its field by giving the green light on an expansion of laboratories at its Wolverhampton headquarters.
The £1.5million investment will increase capacity at the i54 site and will bring even greater food and water testing capabilities, underlining the firm’s commitment to innovation.
The 1,000 square metre development will see food microbiology laboratories expanded on the ground floor, while water hygiene testing will be expanded in a new first floor extension, alongside a larger staff canteen.
This enhances the overall capabilities of the site, complementing the investment in the expansion of food chemistry and contaminants completed in 2016.
Patrick Harte, General Manager at Eurofins Food and Water Testing UK and Ireland, said: “This extension reinforces our commitment to further increasing the services we can offer, harnessing our world-leading laboratory expertise.
“Our investment also means we are future-proofing the facility, widening the scope of what we can offer, giving customers even greater insight to help them make truly informed commercial decisions.”
Eurofins Food and Water Testing UK and Ireland is made up of 11 world-class laboratories and is the world leader in food, feed and water testing, offering a comprehensive range of state-of-the-art analytical techniques to support customers’ increasingly stringent quality and food safety standards.
The company is part of Eurofins Scientific, an international life sciences company which provides a unique range of analytical testing services to clients across multiple industries worldwide.
It is anticipated the new development will be complete by this autumn.
For further editorial information, please contact:
Chris Bentley or Felicity Wingrove | Zen Communications | 01952 200722
Eurofins – a global leader in bio-analysis
Eurofins Scientific through its subsidiaries (hereinafter sometimes “Eurofins” or “the Group”) believes it is the world leader in food, environment and pharmaceutical products testing and that it is also one of the global independent market leaders in certain testing and laboratory services for agroscience, genomics, discovery pharmacology and for supporting clinical studies.
In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA. With over 27,000 staff in 310 laboratories across 39 countries, Eurofins offers a portfolio of over 130,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group objective is to provide its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.